Numbness in chin

•Download as PPTX, PDF•

1 like•82 views

Jamil Kifayatullah

CAUSES OF NUMBNESS IN LIP OR CHIN

Numbness in chin/lip region
JAMEEL KIFAYATULLAH

causes
• neoplastic
• traumatic
• Dental
• Toxic
• drug-induced
• inflammatory
• autoimmune
• infectious

causes
Neoplasm
• breast cancer(40%)
• lymphoma (21%)
• prostate (7%)
• leukaemia (5%)

Causes
Dental and traumatic injury
• Iatrogenic injury
• removal of impacted teeth or cysts
• local anaesthetic block
• bone grafting
• endodontic therapy
• orthognathic surgery
• dental implant placement,

Causes
Toxin or drug-induced
Bisphosphonate
mefloquine
allopurinol
interferon-alpha
trichloroethylene

Causes
Infection
• Syphilis
• Lyme disease
• herpes simplex virus
• human immunodeficiency virus

Causes
Inflammatory/Autoimmune
Multiple sclerosis
sensorimotor mononeuritis multiplex
giant cell arteritis
post-hepatitis B vaccination
systemic lupus erythematosus
Sjögren syndrome
scleroderma
rheumatoid arthritis
mixed connective tissue disease
dermatomyositis

Investigations
• detailed case history along with systematic systemic
and local examination.
• History of all the systems, general health of the patient,
recent illness and weight loss
• radiographic studies:Panoramic radiography
cone-beam computed tomography (CBCT)
Computerized tomography (CT) scan or magnetic
resonance imaging (MRI), with gadolinium
administration, of the head and neck should be done if
possible as these can yield an accurate anatomic image
of the inferior alveolar nerve and its surrounding

Investigations
• Nuclear bone scintigraphy (bone scanning)
may also benefit in identifying mandibular
bone disease such as metastasis or
osteomyelitis

Investigations
• FNAC and biopsy of the lesion are
indispensable for confirmation of the
diagnosis
• Lumbar puncture and cytologic analysis of
cerebrospinal fluid can be of assistance in
cases where radiography is negative

MANAGEMENT PLAN
• Identification of the underlying pathology and
its treatment formulate the basic principle for
management of these cases.
• Patients with NCS caused by dental diseases
may recover after the local conditions have
improved, while those caused by malignancy
are usually treated by analgesic and antitumor
therapy with little effect and poor prognosis.

Similar to Numbness in chin

Periodontal disease [autosaved]

maryam jahangiri

Oralsquamouscellcarcinoma 131027024257-phpapp02

Kishore Chandra Korada

Oral squamous cell carcinoma

preethi95

Premalignant condition

Dr. Haydar Muneer Salih

Mucormycosis

SREENIVAS KAMATH

Desquamative Gingivitis

Dandu Prasad Reddy

Diseases of oral cavity and ludwig’s angina ug,18.07.16 dr.davis thomas

ophthalmgmcri

Diseases of oral cavity and ludwig’s angina ug,18.07.16 dr.davis thomas

ophthalmgmcri

multiple myelomaDrHafeez Yaqoob

Erythema multiforme Dr Chithra P

Dr. Chithra P

Classification of periodontal diseases

Enas Elgendy

Aidsshabeel pn

Oral health2

Notre Dame De Chartres Hospital

Oral Health2

Notre Dame De Chartres Hospital

Oral cavity lesionsNotre Dame De Chartres Hospital

7. tesoro acute myelogenous leukemiaJohn Velo

desquamative ginigivitis

Mehul Shinde

oral manifestations of HIV.pptx

Lubna Nazneen

Oral manifestations of Hematological disorders

Subhash Thakur

Oral ulcers

Marwa Khalifa

Similar to Numbness in chin (20)

Periodontal disease [autosaved]

Oralsquamouscellcarcinoma 131027024257-phpapp02

Oral squamous cell carcinoma

Premalignant condition

Mucormycosis

Desquamative Gingivitis

Diseases of oral cavity and ludwig’s angina ug,18.07.16 dr.davis thomas

multiple myeloma

Erythema multiforme Dr Chithra P

Classification of periodontal diseases

Aids

Oral health2

Oral Health2

Oral cavity lesions

7. tesoro acute myelogenous leukemia

desquamative ginigivitis

oral manifestations of HIV.pptx

Oral manifestations of Hematological disorders

Oral ulcers

Recently uploaded

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

Saeid Safari

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx

FFragrant

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...

kevinkariuki227

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Dr Jeenal Mistry

Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol that is rapidly distributed in the body and brain. Ethanol alters many neurochemical systems and has rewarding and addictive properties. It is the oldest recreational drug and likely contributes to more morbidity, mortality, and public health costs than all illicit drugs combined. The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) integrates alcohol abuse and alcohol dependence into a single disorder called alcohol use disorder (AUD), with mild, moderate, and severe subclassifications (American Psychiatric Association, 2013). In the DSM-5, all types of substance abuse and dependence have been combined into a single substance use disorder (SUD) on a continuum from mild to severe. A diagnosis of AUD requires that at least two of the 11 DSM-5 behaviors be present within a 12-month period (mild AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria). The four main behavioral effects of AUD are impaired control over drinking, negative social consequences, risky use, and altered physiological effects (tolerance, withdrawal). This chapter presents an overview of the prevalence and harmful consequences of AUD in the U.S., the systemic nature of the disease, neurocircuitry and stages of AUD, comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and pharmacotherapies for AUD.

Ocular injury ppt Upendra pal optometrist upums saifai etawah

pal078100

263778731218 Abortion Clinic /Pills In Harare ,

sisternakatoto

263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey

greendigital

Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye. Follow us on: Pinterest Introduction Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing . Early Life and Career Childhood and Athletic Beginnings Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle. Transition to Acting Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness. Fitness Regimen Workout Routine Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show. Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles. Importance of Flexibility and Mobility In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit

New Drug Discovery and Development .....

NEHA GUPTA

The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...

VarunMahajani

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade

Prof. Marcus Renato de Carvalho

Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva. Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade. Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal. Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural. Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis. É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais. O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada. Recomendamos muito. Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos. Esta publicação só está disponível em inglês até o momento. Prof. Marcus Renato de Carvalho www.agostodourado.com

Evaluation of antidepressant activity of clitoris ternatea in animals

Shweta

BRACHYTHERAPY OVERVIEW AND APPLICATORS

Krishan Murari

Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe

Savita Shen $i11

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

Physiology of Chemical Sensation of smell.pdf

MedicoseAcademics

Title: Sense of Smell Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the primary categories of smells and the concept of odor blindness. Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction. Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain. Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential. Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes. Key Topics: Olfactory Genes: 3% of the human genome accounts for olfactory genes. 400 genes for odorant receptors. Olfactory Membrane: Located in the superior part of the nasal cavity. Medially: Folds downward along the superior septum. Laterally: Folds over the superior turbinate and upper surface of the middle turbinate. Total surface area: 5-10 square centimeters. Olfactory Mucosa: Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell. Sustentacular Cells: Produce mucus and maintain ionic and molecular environment. Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months. Bowman’s Gland: Secretes mucus. Stimulation of Olfactory Cells: Odorant dissolves in mucus and attaches to receptors on olfactory cilia. Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve. Quality of a Good Odorant: Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble. Facilitated by odorant-binding proteins in mucus. Membrane Potential and Action Potential: Resting membrane potential: -55mV. Action potential frequency in the olfactory nerve increases with odorant strength. Adaptation Towards the Sense of Smell: Rapid adaptation within the first second, with further slow adaptation. Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system. Primary Sensations of Smell: Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid. Odor Detection Threshold: Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm). Some toxic substances are odorless at lethal concentrations. Characteristics of Smell: Odor blindness for single substances due to lack of appropriate receptor protein. Behavioral and emotional influences of smell. Transmission of Olfactory Signals: From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition. Primitive, less old, and new olfactory systems with different path

ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND

DR SETH JOTHAM

Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum. There are a number of conditions that present acutely, predominantly with pain and/or swelling A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle. Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction. The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent

Knee anatomy and clinical tests 2024.pdf

vimalpl1234

How to Give Better Lectures: Some Tips for Doctors

LanceCatedral

micro teaching on communication m.sc nursing.pdf

Anurag Sharma

Recently uploaded (20)

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Ocular injury ppt Upendra pal optometrist upums saifai etawah

263778731218 Abortion Clinic /Pills In Harare ,

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey

New Drug Discovery and Development .....

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade

Evaluation of antidepressant activity of clitoris ternatea in animals

BRACHYTHERAPY OVERVIEW AND APPLICATORS

Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

Physiology of Chemical Sensation of smell.pdf

ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND

Knee anatomy and clinical tests 2024.pdf

How to Give Better Lectures: Some Tips for Doctors

micro teaching on communication m.sc nursing.pdf

Numbness in chin

1. Numbness in chin/lip region JAMEEL KIFAYATULLAH

2. causes • neoplastic • traumatic • Dental • Toxic • drug-induced • inflammatory • autoimmune • infectious

3. causes Neoplasm • breast cancer(40%) • lymphoma (21%) • prostate (7%) • leukaemia (5%)

4. Causes Dental and traumatic injury • Iatrogenic injury • removal of impacted teeth or cysts • local anaesthetic block • bone grafting • endodontic therapy • orthognathic surgery • dental implant placement,

5. Causes Toxin or drug-induced Bisphosphonate mefloquine allopurinol interferon-alpha trichloroethylene

6. Causes Infection • Syphilis • Lyme disease • herpes simplex virus • human immunodeficiency virus

7. Causes Inflammatory/Autoimmune Multiple sclerosis sensorimotor mononeuritis multiplex giant cell arteritis post-hepatitis B vaccination systemic lupus erythematosus Sjögren syndrome scleroderma rheumatoid arthritis mixed connective tissue disease dermatomyositis

8. Investigations • detailed case history along with systematic systemic and local examination. • History of all the systems, general health of the patient, recent illness and weight loss • radiographic studies:Panoramic radiography cone-beam computed tomography (CBCT) Computerized tomography (CT) scan or magnetic resonance imaging (MRI), with gadolinium administration, of the head and neck should be done if possible as these can yield an accurate anatomic image of the inferior alveolar nerve and its surrounding

9. Investigations • Nuclear bone scintigraphy (bone scanning) may also benefit in identifying mandibular bone disease such as metastasis or osteomyelitis

10. Investigations • FNAC and biopsy of the lesion are indispensable for confirmation of the diagnosis • Lumbar puncture and cytologic analysis of cerebrospinal fluid can be of assistance in cases where radiography is negative

11. MANAGEMENT PLAN • Identification of the underlying pathology and its treatment formulate the basic principle for management of these cases. • Patients with NCS caused by dental diseases may recover after the local conditions have improved, while those caused by malignancy are usually treated by analgesic and antitumor therapy with little effect and poor prognosis.

Numbness in chin

Recommended

Recommended

More Related Content

Similar to Numbness in chin

Similar to Numbness in chin (20)

More from Jamil Kifayatullah

More from Jamil Kifayatullah (20)

Recently uploaded

Recently uploaded (20)

Numbness in chin